1627824-09-2

Basic information

• Product Name: (R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate
• Synonyms: N-[(R)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-1-methylethyl ester-D-Alanine;isopropyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-D-alaninate
• CAS NO: 1627824-09-2
• Molecular Formula: C18H17F5NO7P
• Molecular Weight: 485.295857
• Mol File: 1627824-09-2.mol

Chemical Properties

• Boiling Point: 442.6±55.0 °C(Predicted)
• Appearance: /
• Density: 1.405±0.06 g/cm3(Predicted)
• PKA: -3.81±0.70(Predicted)
• CAS DataBase Reference: (R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate(1627824-09-2)
• EPA Substance Registry System: (R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate(1627824-09-2)

Safety Data

• Hazardous Substances Data: 1627824-09-2(Hazardous Substances Data)

Usage

Uses

Used in Materials Science:
(R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate is used as a component in the development of new materials due to its fluorinated nature and unique structural features, which may contribute to enhanced properties such as thermal stability, chemical resistance, or specific interactions with other molecules.
Used in Pharmaceutical Industry:
(R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate is used as a potential active pharmaceutical ingredient or as an intermediate in the synthesis of drugs, leveraging its chiral centers and functional groups to target specific biological pathways or receptors, thus exhibiting therapeutic effects.
Used in Synthesis of Complex Molecules:
(R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate serves as a building block in the synthesis of more complex organic molecules, where its unique structure and functional groups can be utilized to create novel compounds with specific properties or functions in various applications.
Used in Medicinal Chemistry Research:
(R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate is used as a subject of study in medicinal chemistry to explore its potential as a lead compound for drug discovery, taking advantage of its stereochemistry and functional groups to optimize its interactions with biological targets and improve its pharmacological profile.

Upstream product

• 771-61-9 2,3,4,5,6-pentafluorophenol 
• 770-12-7 O-phenyl phosphorodichloridate 
• 39613-92-8 alanine isopropyl ester hydrochloride 
• 39825-33-7 isopropyl L-alanine 
• 926309-10-6 isopropyl (2R)-2-((chloro(phenoxy)phosphoryl)amino)propanoate 
• 108-21-4 Isopropyl acetate 
• 79487-89-1 (R)-isopropyl 2-aminopropanoate 
• 56-41-7 L-alanin 
• 78-83-1 2-methyl-propan-1-ol 
• 261909-49-3 phenyl(isopropoxy-L-alaninyl) phosphorochloridate 
• 39613-92-8 (R)-1-isopropoxy-1-oxopropan-2-aminium chloride 
• 1256490-52-4 (S)-2-[(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphorylamino]propionic acid isopropyl ester 
• 17788-07-7 2,3,4,5,6-pentafluorophenyl dichlorophosphate 
• 108-95-2 phenol 

Downstream Products

• 1255860-40-2 C₂₃H₃₀N₃O₁₀P 
• 1403574-71-9 C₂₂H₃₀N₇O₈P 
• 1605283-78-0 C₃₁H₄₄N₅O₉P 
• 1605283-80-4 C₃₁H₄₄N₅O₉P 
• 1605283-84-8 C₃₁H₄₂N₅O₁₀P 
• 1605283-86-0 C₂₆H₃₆N₇O₉P 
• 1605283-89-3 C₃₀H₄₂N₇O₁₀P 
• 1605283-90-6 C₂₆H₃₆N₇O₉P 
• 1605283-94-0 C₂₇H₃₅N₄O₁₀P 
• 1231747-08-2 (S)-2-{(S)-[(1R,4R,5R)-5-(2-amino-6-methoxy-purin-9-yl)-4-(R)-fluoro-3-hydroxy-4-methyl-tetrahydrofuran-2-ylmethoxy]phenoxy-phosphorylamino}propionic acid isopropyl ester 

Relevant articles and documents

Design, synthesis and evaluation of 2′-acetylene-7-deaza-adenosine phosphoamidate derivatives as anti-EV71 and anti-EV-D68 agents

A series of phosphoamidate derivatives of nucleoside 2′-acetylene-7-deaza-adenosine (NITD008) were synthesized and evaluated for their in vitro antiviral activities against the enteroviruses EV71 and EV-D68. The phosphoamidate (15f) containing a hexyl est

Nucleotide derivative and pharmaceutical composition and application thereof

The invention discloses a nucleotide derivative and a pharmaceutical composition and application thereof, wherein the nucleotide derivative is as shown in a formula (I). The compound can be used for preparing anti-virus infection drugs.

Prodrug compound and application ofprodrug compound in treatment of cancer

The present invention provides a compound indicated by a formula (I), pharmaceutically acceptable salts or esters thereof, a pharmaceutical composition of the compound, and application of the compoundand the pharmaceutical composition in the inhibition or regulation of the activity of tyrosine kinase and treating disease symptoms or symptoms including cancer mediated by tyrosine kinase.

PRODRUGS OF THE TYROSINE KINASE INHIBITOR FOR TREATING CANCER

There are provided compounds of Formula (I), and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, useful for inhibition or modulation of the activity of tyrosine kinases and treatment of disease states or conditions mediated by tyrosine kinases, including cancers. (I)

CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF

An object of the present invention is to provide a compound exhibiting an excellent drug efficacy as an anti-adenoviral agent, and an anti-adenoviral agent. The present invention provides a compound represented by General Formula [1] (in the formula, R1 represents a halogen atom, an amino group which may be substituted, a C1-6 alkoxy group which may be substituted, a hydroxyl group which may be protected, or the like; R2 represents a hydrogen atom or an amino protecting group; R3 represents a C1-20 alkoxy group which may be substituted, an aryloxy group which may be substituted, an amino group which may be substituted, or the like; R4 represents a C1-20 alkoxy group which may be substituted, an aryloxy group which may be substituted, an amino group which may be substituted, or the like); or a salt thereof.

2,4,7-SUBSTITUTED-7-DEAZA-2'-DEOXY-2'-FLUOROARABINOSYL NUCLEOSIDE AND NUCLEOTIDE PRO-DRUGS AND USES THEREOF

The present disclosure is concerned with 2,4,7-substituted-7-deaza-2'-deoxy-2'- fluoroarabinosyl nucleoside and nucleotide prodrugs that are capable of inhibiting viral infections and methods of treating viral infections such as, for example, human immunodeficiency virus (HIV), human papillomavirus (HPV), herpes simplex virus (HSV), human cytomegalovirus (HCMV), chicken pox, infectious mononucleosis, mumps, measles, rubella, shingles, ebola, viral gastroenteritis, viral hepatitis, viral meningitis, human metapneumovirus, human parainfluenza virus type 1, parainfluenza virus type 2, parainfluenza virus type 3, respiratory syncytial virus, viral pneumonia, Chikungunya virus (CHIKV), Venezuelan equine encephalitis (VEEV), dengue (DENV), influenza, West Nile virus (WNV), zika (ZIKV), 229E, NL63, OC43, HKU1, Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), and severe acute respiratory syndrome coronavirus disease 2019 (SARS-CoV-2), using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Preparation method for phosphamide compound used for synthesis chiral drug

The invention provides a preparation method for a phosphamide compound used for synthesis of a chiral drug. According to the invention, a compound II with high yield and high purity can be prepared byadopting a NaHCO3 aqueous solution with a specific pH value and a specific volume-to-mass ratio as a solvent for pulping and controlling a temperature and a stirring speed during pulping. By adoptionof a reaction system provided by the invention, an organic solvent is not needed; the discharge of a large amount of an organic solvent waste liquid is reduced; and the process is environmentally-friendly, green and pollution-free.

Pyrrolotriazine compound, composition and application thereof

The invention relates to a pyrrolotriazine compound, a composition and an application thereof, the pyrrolotriazine compound has a structure as shown in a formula (I), and the definitions of R1-R11 areas defined in claim 1. The pyrrolotriazine compound has an excellent antiviral effect, and particularly can be used for preparing drugs for treating feline coronavirus infection-resistant diseases, such as feline infectious peritonitis.

THIARABINE- AND THIARABINE PRODRUG-BASED TREATMENTS

The present disclosure is concerned with combination therapies that include sulfur- based nucleotide and nucleoside compounds for the treatment of various cancers such as, for example, sarcomas, carcinomas, hematological cancers, solid tumors, breast cancer, cervical cancer, gastrointestinal cancer, colorectal cancer, brain cancer, skin cancer, prostate cancer, ovarian cancer, bladder cancer, thyroid cancer, testicular cancer, pancreatic cancer, endometrial cancer, melanomas, gliomas, leukemias, lymphomas, chronic myeloproliferative disorders, myelodysplastic syndromes, myeloproliferative neoplasms, and plasma cell neoplasms (myelomas). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Method for preparing sofosbuvir intermediate by using microfluid reaction device

The invention discloses a method for preparing a sofosbuvir intermediate by using a microfluid reaction device. The method comprises the following steps: pumping phenyl dichlorophosphate and pentafluorophenol into a first micro-channel reactor, carrying o